Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy (Q33502912)

27 July 2017

1 reference

title

Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy (English)

1 reference

heparin-induced thrombocytopenia

27 July 2017

1 reference

1 reference

1 reference

1 reference

Walenga JM

1

1 reference

27 July 2017

Bick RL

series ordinal

2

1 reference

27 July 2017

publication date

1 May 1998

1 reference

Medical Clinics of North America

27 July 2017

published in

1 reference

27 July 2017

volume

82

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

635-658

1 reference

Heparin-induced thrombocytopenia and heart operation: management with tedelparin

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-induced thrombocytopenia and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Immune endothelial-cell injury in heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Thrombocytopenia associated with low-molecular-weight heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Critical ischemia during heparin-induced thrombocytopenia. Treatment by intra-arterial streptokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Pregnancy complicated by heparin associated thrombocytopenia: Management by a prospectively in vitro selected heparinoid (ORG 10172)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-associated thrombocytopenia: immune complexes are attached to the platelet membrane by the negative charge of highly sulphated oligosaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Intraoperative management of patients with heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Cutaneous necrosis caused by systemically administered heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-induced skin necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-induced cutaneous necrosis unrelated to injection sites. A sign of potentially lethal complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Low-molecular-weight heparin in extracorporeal circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-induced thrombocytopenia: a possible complication of heparin-coated pulmonary artery catheters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Long-term administration of heparin and heparin fractions and osteoporosis in experimental animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin fails to potentiate the effects of IL-1 beta-mediated bone resorption of fetal rat long bones in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Skin necrosis due to intravenous heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Use of low-molecular-weight heparin in heparin-induced thrombocytopenia with thrombotic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

New data on the pharmacology of heparin and low molecular weight heparins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Bone density studies in pregnant women receiving heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin‐induced thrombocytopenia: an improved method of detection based on lumi‐aggregometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

Arterial Embolism Occurring During Systemic Heparin Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970015-8

10.1016/S0025-7125(05)70015-8

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference